Cargando…

Engineering Ferroptosis Inhibitors as Inhalable Nanomedicines for the Highly Efficient Treatment of Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) refers to chronic progressive fibrotic interstitial pneumonia. It is called a “tumor-like disease” and cannot be cured using existing clinical drugs. Therefore, new treatment options are urgently needed. Studies have proven that ferroptosis is closely related to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Mengqin, Peng, Tingting, Wu, Chuanbin, Pan, Xin, Huang, Zhengwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295167/ https://www.ncbi.nlm.nih.gov/pubmed/37370658 http://dx.doi.org/10.3390/bioengineering10060727

Ejemplares similares

Low Drug Loading Hampers the Clinical Translation of Peptide Drugs-Containing Metered-Dose Inhalers
por: Huang, Zhengwei, et al.
Publicado: (2022)

Transitions and touchpoints in idiopathic pulmonary fibrosis
por: Swigris, Jeffrey J
Publicado: (2018)

Unraveling the pulmonary drug delivery carriers in inhalable nanostructures
por: Huang, Zhengwei, et al.
Publicado: (2022)

Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment
por: Al-Hatamleh, Mohammad A. I., et al.
Publicado: (2019)

Nanomedicine formulations for combination therapies
por: Lammers, Twan, et al.
Publicado: (2010)

Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities
por: Nichols, Dave P., et al.
Publicado: (2019)

Bibliometric landscape of the researches on protein corona of nanoparticles
por: Huang, Zhengwei, et al.
Publicado: (2021)

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2022)

The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis
por: Usmani, Omar S., et al.
Publicado: (2018)

Ferroptosis-Inducing Nanomedicine for Cancer Therapy
por: Wang, Yang, et al.
Publicado: (2021)

Mapping the intersection of nanotechnology and SARS-CoV-2/COVID-19: A bibliometric analysis
por: Zhang, Xuejuan, et al.
Publicado: (2022)

Biomedical photoacoustics: fundamentals, instrumentation and perspectives on nanomedicine
por: Zou, Chunpeng, et al.
Publicado: (2016)

Roadmap and strategy for overcoming infusion reactions to nanomedicines
por: Szebeni, Janos, et al.
Publicado: (2018)

Nanomedicine sheds new light on cancer immunotherapy
por: Yu, Yingying, et al.
Publicado: (2023)

Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis
por: Velino, Cecilia, et al.
Publicado: (2019)

Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis
por: John, Alison E., et al.
Publicado: (2020)

The eminent need for an academic program in universities to teach nanomedicine
por: Vélez, Juan Manuel, et al.
Publicado: (2011)

Biomaterials and nanomedicine for bone regeneration: Progress and future prospects
por: Zhou, Jun, et al.
Publicado: (2021)

Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis
por: Lu, Peng, et al.
Publicado: (2022)

Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
por: Chennakesavulu, S., et al.
Publicado: (2018)

Nanomedicine concepts in the general medical curriculum: initiating a discussion
por: Sweeney, Aldrin E
Publicado: (2015)

Self-driving laboratories: A paradigm shift in nanomedicine development
por: Hickman, Riley J., et al.
Publicado: (2023)

“One-for-All” approach: a black technology for nanomedicine development?
por: Xiang, Jiajia, et al.
Publicado: (2023)

Mitochondrial regulation of ferroptosis
por: Gan, Boyi
Publicado: (2021)

Importance of Standardizing Analytical Characterization Methodology for Improved Reliability of the Nanomedicine Literature
por: Sharifi, Shahriar, et al.
Publicado: (2022)

Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study
por: Wright, Caroline E., et al.
Publicado: (2017)

Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis
por: Hirani, Nikhil, et al.
Publicado: (2021)

Ferroptosis-Related Genes in Bronchoalveolar Lavage Fluid Serves as Prognostic Biomarkers for Idiopathic Pulmonary Fibrosis
por: Li, Meng, et al.
Publicado: (2021)

Research Progress and Hopeful Strategies of Application of Quorum Sensing in Food, Agriculture and Nanomedicine
por: Abbamondi, Gennaro Roberto, et al.
Publicado: (2022)

Opportunities for Ferroptosis in Cancer Therapy
por: Fujihara, Kenji M., et al.
Publicado: (2021)

Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo
por: Luo, Yifeng, et al.
Publicado: (2021)

Evaluation of Proteasome Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
por: Chen, I-Chen, et al.
Publicado: (2022)

Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis
por: Yang, Xudan, et al.
Publicado: (2023)

Prospective Application of Nanoparticles Green Synthesized Using Medicinal Plant Extracts as Novel Nanomedicines
por: Selvakesavan, Rajendran K, et al.
Publicado: (2021)

Nanomedicine for the poor: a lost cause or an idea whose time has yet to come?
por: Uskoković, Vuk
Publicado: (2021)

Future Treatment of Neuropathic Pain in Spinal Cord Injury: The Challenges of Nanomedicine, Supplements or Opportunities?
por: Forte, Giuseppe, et al.
Publicado: (2022)

Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administration
por: Heida, Rick, et al.
Publicado: (2023)

An Autopsy Case of An Acute Exacerbation of Idiopathic Pulmonary Fibrosis Triggered by the Inhalation of a Waterproofing Spray
por: Kawaguchi, Takako, et al.
Publicado: (2021)

Multiplying the efficiency and impact of biofortification through metabolic engineering
por: Van Der Straeten, Dominique, et al.
Publicado: (2020)

Reductions in inhaler greenhouse gas emissions by addressing care gaps in asthma and chronic obstructive pulmonary disease: an analysis
por: Gagné, Myriam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_urp1gfeuk0jaarr6jva3imci2f